Stichting MedtechPartners

🚨 It's official: Registration for the HealthTech Investor Summit 2026 is now open. This November, Europe's HealthTech ecosystem comes together in Bruges. Over three days, founders, investors, leaders and innovators will connect, share ideas, discover breakthrough technologies and shape the future of healthcare 🚀 🧐 Looking to increase your visibility? Why not partner with us? Partnership opportunities are still avaialble for organizations that want to be part of Europe's leading HealthTech investor event. 💡 Are you building the next breakthrough in HealthTech? The Pan-European Pitching Selections will be opening soon, giving pre-seeds, startups and scale-ups innovators the opportunity to pitch in front of leading investors and industry experts. Whether you're looking to invest, grow your network, find new partners, or explore the latest innovations, #HIS2026 is the place to be. ☀️ And a little extra for early planners: Register now and take advantage of our Summer Sale, offering 20% off your ticket. Join us now 🔽 📅 30 November - 2 December 📍 BMCC, Bruges 🔗 https://lnkd.in/esusfD8p The HealthTech Investor Summit is organized by Biovia and supported by VLAIO - Flanders Innovation & Entrepreneurship #HIS2026 #healthtech #investment #funding #venturecapital #medtech #digitalhealth #stronggrowth

DigitalHealthMeeting at Brainport today Great DigitalHealthMeeting this afternoon in Brainport Eindhoven. Thanks Quirine Verstappen and Emiel Westerhof for hosting todays meeting! Quirine and Emiel started the meeting with sharing all great developments in Brainport and the start of Cureon. Then five pitchers presented their innovations: 👉 Geert van Kollenburg showed how Precubitus can objectively measure tissue to prevent ulcers 👉 Jurriaan van Rijswijk M Sc explained how Neo-Diary can support parents of neonatal patients 👉 Chaja F. Jacobs presented how @Samadhi’s Secrets offers support for patients between clinical appointments 👉 Mohammad Samheel demonstrated how OSIND MEDI TECH BV improves hand rehabilitation through a personalised orthosis 👉 Joey van Rooijen explained how U-Care improves care coordination and patient support. All five pitchers had great interaction with our expert partners resulting in a lot of matches to help with further development of their innovations. Followed off course by our network drinks. Want to know more about our programs? Tijmen Troost and Joep Welschen are happy to tell you more! Powered by Health Holland and KplusV

𝐑𝐨𝐭𝐭𝐞𝐫𝐝𝐚𝐦 𝐒𝐪𝐮𝐚𝐫𝐞 𝐥𝐚𝐮𝐧𝐜𝐡𝐞𝐬 𝐭𝐡𝐞 𝐍𝐋 𝐔𝐒𝐀 𝐇𝐞𝐚𝐥𝐭𝐡 𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐨𝐫 𝐢𝐧 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐰𝐢𝐭𝐡 𝐂𝐞𝐝𝐚𝐫𝐬-𝐒𝐢𝐧𝐚𝐢 𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐨𝐫+ 𝐚𝐧𝐝 𝐄𝐫𝐚𝐬𝐦𝐮𝐬 𝐌𝐂 We are pleased to announce the launch of the NL USA Health Accelerator, a new international initiative by Rotterdam Square in collaboration with Cedars-Sinai Accelerator+ and Erasmus MC. The program will be unveiled at HLTH Europe. The NL USA Health Accelerator is designed to help high-potential Dutch Health, MedTech, biotech and digital health companies accelerate their entry into the U.S. healthcare market. The program combines the clinical and research expertise of Erasmus MC with the innovation, commercialization and market access capabilities of Cedars-Sinai Accelerator+.  “Cedars-Sinai Accelerator+ is committed to helping promising healthcare companies understand and navigate the U.S. healthcare market. Through this program, we look forward to supporting Dutch startups as they refine their solutions and explore opportunities to address healthcare challenges in the U.S. and beyond.”  — Nirdesh K Gupta, PhD, Managing Partner, Cedars-Sinai Technology Ventures  “International collaboration is essential to accelerate healthcare innovation and bring it to patients. By joining forces with Cedars-Sinai and Rotterdam Square, we strengthen the connection between clinical expertise, research and entrepreneurship.”  — Dirk Schraven, Member of the Executive Board, Erasmus MC 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧𝐬 𝐧𝐨𝐰 𝐨𝐩𝐞𝐧 (𝐉𝐮𝐧𝐞 𝟏𝟓 – 𝐀𝐮𝐠𝐮𝐬𝐭 𝟐𝟖) For startups and scale-ups with a validated product, MVP or proof-of-concept and international ambition. 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐟𝐮𝐥𝐥 𝐩𝐫𝐞𝐬𝐬 𝐫𝐞𝐥𝐞𝐚𝐬𝐞: https://lnkd.in/e5-5Vc5A 𝐌𝐨𝐫𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 & 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧: https://lnkd.in/eNQvDbwS #HealthTech #MedTech #Biotech #DigitalHealth #Innovation #Startups #ErasmusMC #CedarsSinai #RotterdamSquare #wheretechmeetshealthcare #accelerator #NLUSAHealthAccelerator

Vooraankondiging - MKB Call 2027 ⭐️ Health Holland publiceert in september 2026 een nieuwe ronde van de MKB Call, en stelt hiervoor minimaal €8 miljoen PPS-subsidie beschikbaar (waarvan €5 miljoen specifiek voor mkb-partijen). Met deze call stimuleren we publiek-private R&D in de Life Sciences & Health (LSH) sector om het Nederlands economisch verdienvermogen te versterken en maatschappelijke impact te vergroten. 🔎 Focus van de call Het mkb speelt een sleutelrol in innovatie. Met deze call kunnen mkb-partijen hun ontwikkelcapaciteit versterken, R&D-medewerkers aantrekken of behouden en samen met onderzoeksorganisaties werken aan de verdere ontwikkeling van nieuwe of verbeterde producten, diensten of processen. 👥 Voor wie? De call is bedoeld voor: • Consortia met als hoofdaanvrager een in Nederland gevestigde mkb-onderneming met winstoogmerk. • In samenwerking met onderzoeksorganisaties in de LSH-sector. 💶 Subsidie & planning • Maximale looptijd van twee jaar • Per project: Nederlands mkb: max. €150.000 PPS-subsidie per projectjaar Nederlandse onderzoeksorganisaties: max. €150.000 PPS-subsidie  • Co-financiering door alle consortiumpartners is vereist • 1 september 2026: publicatie volledige call 👥 Beoordelingsprocedure • Fase 1: Opstellen en indienen volledige aanvraag (verwachte deadline 20 november 2026) • Fase 2: Voorselectie op basis van video-pitch en selectieve vragen in het aanvraagformulier (communicatie resultaat voorselectie rond februari 2027) • Fase 3: Volledige inhoudelijke beoordeling (communicatie resultaat rond mei 2027) ⚠️ Let op: De MKB-call is een populaire en competitieve subsidie-oproep. Door het grote aantal aanvragen (gemiddeld 80+ aanvragen per ronde) en beperkte middelen wordt een beoordelingsprocedure met voorselectie gehanteerd. Health Holland is voornemens om maximaal 40 projecten te laten doorstromen naar de volledig inhoudelijke beoordelingsfase, en verwacht op basis van het beschikbare budget +/-20 projecten te kunnen honoreren. ⚠️Verklaring geen onderneming in moeilijkheden (OIM) Volgens de huidige wet- en regelgeving dienen Nederlandse ondernemingen die subsidie aanvragen binnen de MKB Call geen onderneming in moeilijkheden te zijn volgens de definitie. Het bedrijf dient op het moment van indiening een verklaring geen OIM volgens het RVO template te kunnen overleggen. Deze verklaring is te verkrijgen door het beslisschema in te vullen op de website van Rijksdienst voor Ondernemend Nederland (RVO). Hier vind je ook meer informatie over de toets. ℹ️ Meer weten? Ga naar: https://lnkd.in/esX3-QzN 📩 Contact Vragen of alvast verkennen of jullie idee past? Neem contact op met Sten en Florine via tki@health-holland.com

Don't miss your shot!⛹️ Less than 1 week left to apply for the pre-selection! HealthTech founders across Europe are already securing their place in the HealthTech Investor Summit 2026 regional pre-selections and you should too 🫵 The regional pre-selections are your opportunity to fast-track your path to Europe's leading HealthTech investor event and secure your place before the pan-European selections. By waiting, you're risking: 🏆 Missing out on up to 30% off your pitching package 📚 Losing valuable preparation time 🔎Watching competitors secure their spot before you If you're a HealthTech startup, scale-up or pre-seed company with operations in Europe, now is the time to act. 🚨 Applications close on 15 June 2026 🚨 If you've been considering applying, now is the moment to submit your application and secure your chance to compete for a place in Bruges! Apply now 👇 https://lnkd.in/ezzmtf8k Contact your country's Knowledege Partner: Biovia Bioindustry Park Silvano Fumero S.p.A. Società Benefit, bioPmed - Piemonte Healthcare Cluster, BioVille, Clust-ER Health - Emilia-Romagna, Connected Health & Wellbeing Cluster, France Deeptech, Health and Life Sciences Cluster Bulgaria - BioCluster.bg, Health Campus Limburg DC, Health Cluster Portugal, Health Hub Tirol, Hellenic Digital Health Cluster (HDHC), Health Innovation and Ventures Enabler (Hive), IGNITY, IMAGO-MOL Cluster, imec.istart, Kuopio Health, lifetech.brussels, LISA - Life Science Austria, Stichting MedtechPartners, Prague.bio, Rotterdam Square, X-Novation Center #HIS2026 #healthtech #investment #funding #venturecapital #medtech #digitalhealth

Matchingevent vandaag in ‘s-Hertogenbosch   Als zorginnovator kan het soms lastig zijn om in contact te komen met de juiste partijen om je zorginnovatie verder te helpen. Om daarbij te ondersteunen organiseerden Zorginnovatie.nl en Zorg voor innoveren vandaag een Matchingevent.     Naast Nederlandse Zorgautoriteit (NZa), Zorginstituut Nederland, Rijksdienst voor Ondernemend Nederland (RVO), Coöperatie VGZ, CbusineZ, NextGen Ventures, BOM (Brabantse Ontwikkelings Maatschappij), Health Holland, Zorginnovatie en Zorg voor innoveren waren Tijmen Troost en Joep Welschen van het Stichting MedtechPartners team aanwezig om ondernemers verder op weg te helpen.   Mooi event en goede gesprekken tussen innovatoren en experts!

HealthTech Investor Summit 2026 regional pitching pre-selections are open! Applications are now open for the regional pitching pre-selections for the HealthTech Investor Summit 2026, taking place in Bruges, 30 Nov – 2 Dec. What is a pre-selection? Before the pan-European pitching selections in June, we run regional competitions across Europe where HealthTech companies compete to already earn their spot on the HIS stage, and unlock serious discounts on their pitching package. Think of it as your local qualifier for Europe's biggest HealthTech investor event. 🏆 Why apply for the pre-selection, and not just to the pan-European selections later on? ✅ Win your regional pre-selection and get up to 30% off your pitching package ✅ 2nd place gets 20% off, 3rd and 4th get 15% off ✅ These discounts stack the discount that we as Knowledge Partner can offer (extra discount (15%) ✅ Deadline to apply: June 15 Pre-selections are running across Europe 🌍 Who can apply? Private HealthTech companies (pre-seed, start-up, or scale-up) with significant operations in Europe, working on tech-driven health solutions. Don't wait for the main call, get in early, get on stage, and get in the room with 100+ investors. 👇 https://lnkd.in/ezzmtf8k

The journey from startup to scale-up in medtech is rarely defined by a single milestone. From regulatory progress to market adoption, different moments can signal that a company is ready to scale. We’re curious how you define this transition.👇 

𝗣𝗮𝗿𝘁𝗻𝗲𝗿 𝗶𝗻 𝘁𝗵𝗲 𝗣𝗶𝗰𝘁𝘂𝗿𝗲 At Het Marketing Lab - Marketing, Communicatie & AI voor Zorg & Life Sciences, Fleur Prins 🧪 supports Life Science & Health organizations in communicating their story in a clear and accessible way, both verbally and visually. 𝙒𝙝𝙖𝙩 𝙞𝙨 𝙩𝙝𝙚 𝙗𝙞𝙜𝙜𝙚𝙨𝙩 𝙘𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚 𝙮𝙤𝙪 𝙨𝙚𝙚 𝙈𝙚𝙙𝙏𝙚𝙘𝙝 𝙘𝙤𝙢𝙥𝙖𝙣𝙞𝙚𝙨 𝙛𝙖𝙘𝙚? "Many innovative companies focus heavily on developing their product, but underestimate the importance of positioning, visibility, and consistent communication. A strong product alone is rarely enough. Investors, partners, and customers first need to understand why your solution matters and what makes it different." 𝙒𝙝𝙖𝙩 𝙞𝙨 𝙩𝙝𝙚 𝙗𝙞𝙜𝙜𝙚𝙨𝙩 𝙞𝙨𝙨𝙪𝙚 𝙮𝙤𝙪 𝙨𝙚𝙚 𝙧𝙚𝙜𝙖𝙧𝙙𝙞𝙣𝙜 𝙢𝙖𝙧𝙠𝙚𝙩𝙞𝙣𝙜 𝙞𝙣 𝙩𝙝𝙚 𝙢𝙖𝙧𝙠𝙚𝙩? "One of the most common challenges is that companies start communicating too late, or without a clear strategy. Messaging becomes inconsistent, websites stay outdated, and valuable opportunities are missed because the story behind the innovation is not reaching the right audience clearly." 𝙒𝙝𝙮 𝙙𝙤 𝙮𝙤𝙪 𝙩𝙝𝙞𝙣𝙠 𝙩𝙝𝙚𝙮 𝙨𝙩𝙖𝙧𝙩 (𝙩𝙤𝙤) 𝙡𝙖𝙩𝙚 𝙬𝙞𝙩𝙝 𝙩𝙝𝙚𝙞𝙧 𝙢𝙖𝙧𝙠𝙚𝙩𝙞𝙣𝙜? "Startups often have limited time and resources. Marketing can quickly feel overwhelming or become something that is only picked up when there is “time”. Effective communication is not about doing everything, but about creating clarity and consistency across content, branding, and visual communication." Through strategy, content creation, branding, design, and AI-driven support, Het Marketing Lab - Marketing, Communicatie & AI voor Zorg & Life Sciences helps organizations communicate in a way that fits both their innovation and their audience. In short: “A strong innovation deserves communication that is clear, recognizable, and trustworthy.” | Powered by the network of Stichting MedtechPartners |

Leuke post van Health Holland over ons MTP Custom Support Program en het concrete praktijkvoorbeeld van deelnemer Syntric Medical.